Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone.
Urinary excretion of the cross-linked alpha 2(I) N-telopeptide (NTx) of type I collagen has proven in clinical studies to provide a highly responsive and specific index of bone resorption. In order to understand better the biological basis of the specificity and responsiveness of this marker, we examined whether osteoclasts cultured on human bone could generate immunoreactive NTx peptide. Mouse bone marrow cultures stimulated with 1,25 diliydroxyvitamin D3 (1,25(OH)2D3) and hydrocortisone to produce osteoclasts, were cocultured on human bone particles or dentin slices. Aliquots of culture medium were assayed for NTx by enzyme-linked immunosorbent assay (ELISA). NTx was detected in the medium 5 days after the addition of bone and continued to be produced linearly over the 14-day culture period. NTx production required attachment to the bone particles or dentin slices of mononuclear and multinuclear cells that stained for tartrate-resistant acid phosphatase. Surface area of resorbed dentin was highly correlated with medium NTx concentration (R2 = 0.84). Production of NTx was suppressed by the osteoclast inhibitors, calcitonin and alendronate, in a dose-dependent manner. Two other markers of bone resorption, hydroxylysyl pyridinoline and lysyl pyridinoline, were found in peptide linkage in the culture medium but not in free form; indicating that the osteoclasts had degraded the bone collagen to peptides but not to the free cross-linking amino acids.
Apone
S
S
Ostex International, Inc., Seattle, WA 98134, USA. sa@nwlink.com
Lee
M Y
MY
Eyre
D R
DR
D000135:Acid Phosphatase / Q000032:analysis; D019386:Alendronate / Q000494:pharmacology; D000596:Amino Acids / Q000032:analysis; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D015415:Biomarkers / Q000032:analysis; D001853:Bone Marrow / Q000187:drug effects; D001862:Bone Resorption / Q000378:metabolism*; D002116:Calcitonin / Q000494:pharmacology; D002117:Calcitriol; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D003094:Collagen / Q000096:biosynthesis* / Q000737:chemistry; D024042:Collagen Type I; D003470:Culture Media / Q000032:analysis; D003804:Dentin / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005269:Femur / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone; D007527:Isoenzymes / Q000032:analysis; D051379:Mice; D008807:Mice, Inbred BALB C; D010010:Osteoclasts / Q000187:drug effects / Q000378:metabolism*; D010452:Peptide Biosynthesis; D010455:Peptides / Q000737:chemistry; D018003:Receptors, Calcitonin / Q000737:chemistry / Q000378:metabolism; D000071681:Tartrate-Resistant Acid Phosphatase
D000596:Amino Acids; D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D024042:Collagen Type I; D003470:Culture Media; D007527:Isoenzymes; D010455:Peptides; D018003:Receptors, Calcitonin; C052929:collagen type I trimeric cross-linked peptide; C015484:pyridinoline; D002116:Calcitonin; D003094:Collagen; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase; D002117:Calcitriol; D006854:Hydrocortisone; D019386:Alendronate